Home › Breast Cancer › NCT06507930
The COMPASSION Study
Recruiting
The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients With Metastatic Breast Cancer Receiving Hospice Care
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patient of any gender with unresectable locally advanced or metastatic breast cancer * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment * Ability to conduct video or phone check-ins, even if assistance required. * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able * Hospice setting is within Massachusetts * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment Exclusion Criteria: * Unable to provide verbal consent * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting) * Hospice setting outside of Massachusetts * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.
About the study
The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.
What is being tested
- Telehealth Hospice Visits (other)
Sponsor: Dana-Farber Cancer Institute · Participants: 200 · Started: Sep 1, 2024
Contact the study team
- Claire Smith, MD · Phone: 617-632-3800
Official record on ClinicalTrials.gov — NCT06507930
Locations in the U.S.
| Massachusetts | Dana-Farber Cancer Institute, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.